For Healthcare Professionals

Early Surgery Versus Conventional Treatment for Asymptomatic Severe Mitral Regurgitation

clipboard-pencil

About the study

The timing of surgical intervention in asymptomatic patients with severe degenerative mitral regurgitation (MR) remains controversial. The benefit of early surgery has been suggested in prospective, observational studies, whereas a watchful waiting strategy seemed to be safe and effective in the other prospective study. The consensus guidelines for the performance of early surgery in asymptomatic patients with severe MR are different, reflecting controversy. Clinical outcome in asymptomatic patients with MR is poorly defined and it is important to identify high-risk patients in whom early surgery may be warranted. Thus, the investigators try to compare long-term outcomes of early surgery with those of a conventional-treatment strategy in a large prospective cohort of asymptomatic patients with severe degenerative MR using a propensity analysis, and to identify high-risk subgroups to whom early surgery is more beneficial.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Inclusion Criteria:


  1. asymptomatic patients
  2. severe degenerative MR
  3. preserved left ventricular systolic function

EXCLUSION CRITERIA

Exclusion Criteria: According to the recommendations of the 2006 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for surgical indications of severe MR, the criteria for exclusion from the study are defined as follows.


  1. patients with the presence of exertional dyspnea, or angina
  2. left ventricular ejection fraction < 0.60
  3. left ventricular end-systolic dimension > 40 mm
  4. atrial fibrillation
  5. significant aortic valve disease
  6. Doppler-estimated systolic pulmonary artery pressure > 50 mmHg
  7. patients who were not candidates for early surgery based on age > 80 years and coexisting malignancies
  8. patients who did not consent to participate

pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Contition

Mitral Regurgitation

Age (in years)

20 - 80

Participants needed

600

Est. Completion Date

Aug 31, 2023

Treatment type

Observational


Sponsor

Asan Medical Center

ClinicalTrials.gov identifier

NCT01703806

Study number

20070264

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.